ALS

Neuroscientist Véronique Belzil, PhD, MS

Belzil to establish VUMC ALS Research Center

Neuroscientist Véronique Belzil, PhD, MS, will join Vanderbilt University Medical Center as associate professor of Neurology and director of ALS (amyotrophic lateral sclerosis) research.

A window display in Medical Center East is helping educate clinicians about alternative communication methods for patients who have difficulty communicating.

Initiative helps patients with communication disorders

Vanderbilt’s Department of Hearing and Speech Sciences is working to educate clinicians about augmentative and alternative communication methods for patients with communication disorders.

Evan Campa and Eben Cathey, along with their children, Mae and Reuben, are helping to raise funds to create an ALS research program at VUMC.

Local family shines in campaign to establish ALS research program

Evan Campa and her family are at the forefront of a campaign to establish an ALS basic science research program at Vanderbilt.

The team studying the regulation of innate immune response includes (front row, from left) Yang Zhao, Antiana Richardson, (back row, from left) John Karijolich, PhD, Xiang Ye and William Dunker.

Study finds that regulatory protein prevents signaling that triggers cell death

A protein implicated in neurodegenerative diseases including amyotrophic lateral sclerosis prevents the activation of an innate immune response that leads to cell death, Vanderbilt researchers have discovered.

Protein study may be key to treating fibrotic diseases

A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt University Medical Center reported recently.

Meeting the challenge

Members of Vanderbilt’s ALS clinic stepped up and took the ice bucket challenge Wednesday to raise awareness for amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.